Michael Harsh - 02 Jan 2024 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)

Role
Director
Signature
/s/ Michael Harsh by Mark Busch, attorney-in-fact
Issuer symbol
NDRA
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
23 Feb 2024, 17:00:41 UTC
Previous filing
03 Aug 2023
Next filing
01 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NDRA Stock Options Award $0 +600 $0.000000 600 02 Jan 2024 Common Stock 600 $1.59 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy.
F2 This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025.